FLORENCE, S.C., July 26, 2016 -- DeGen Medical has received clearance from the FDA for its F1 MPS™ Modular Pedicle Screw System for JOUST™ Minimally Invasive Surgery (MIS) procedure. The JOUST™ MIS is a modular pedicle screw with cobalt-chrome alloy head for percutaneous procedures.
The JOUST™ MIS technology includes MIS Towers for percutaneous screw placement, traditional or cortical approach, and rod reduction is built in the Tower. The unique Rod Insertion Tool with JOUST™ Minimally Invasive Rods aids in achieving a stable fusion construct without undergoing the traditional open approach. JOUST™ MIS procedure allows the surgeon to place the pedicle screws with minimal muscle stripping causing reduced muscle damage and lessening scar tissue formation from decreased dissection. The robust instrumentation allows for smooth implantation in a complex lumbar spine surgery over multiple levels.
The JOUST™ MIS technology with F1 MPS™ System will be available in Q4 of 2016.
About DeGen Medical, Inc.
DeGen Medical, Inc. is a medical-device development company dedicated to providing surgeons with innovative products engineered to improve quality of life for patients with complex spinal disorders. World-class implants, coupled with intuitively-designed instrumentation, provide a complete package to promote superior surgical outcomes. Our passion to advance spine-care solutions is driven by clinical insights, sound research, and science-based design. DeGen Medical maintains the highest quality standards to provide reliable products and safeguard patient health.
|
|||||
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=40928
CONTACT: For more information, please contact:
Jessica Clark
DeGen Medical, Inc.
Phone: 877-240-7838
www.DeGenmedical.com


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Washington Post Publisher Will Lewis Steps Down After Layoffs 



